Resolved a new management structure effective March 25, 2026. Mr. Takeo Morooka was appointed as a new director, and Mr. Christopher Cargill was reappointed as Representative Executive Officer, President & CEO.<\/p>\n","protected":false},"comment_status":"open","ping_status":"closed","template":"","meta":{"Ticker":"","DATE":"","longName":"","company_name_ja":"","fullTimeEmployees":0,"address":"","phone":"","website":"","industry":"","sector":"","regularMarketPrice":0,"financialCurrency":"","marketCap":0,"fiftyTwoWeekLow":0,"fiftyTwoWeekHigh":0,"epsTrailingTwelveMonths":0,"epsForward":0,"bookValue":0,"totalRevenue":0,"OperatingIncome":0,"operatingMargins":0,"NetIncome":0,"profitMargins":0,"ebitda":0,"trailingPE":0,"forwardPE":0,"priceToBook":0,"returnOnEquity":0,"recommendationMean":0,"recommendationKey":"","targetMeanPrice":0,"numberOfAnalystOpinions":0,"analyst_earnings_data":"","dividendRate":0,"dividendYield":0,"payoutRatio":0,"totalEsg":0,"environmentScore":0,"socialScore":0,"governanceScore":0,"title":"","providerPublishTime":"","link":"","longBusinessSummary":"","longBusinessSummary_ja":"","quarterly_revenue":0,"quarterly_net_income":0,"quarterly_operating_profit":0,"enterprise_value":0,"company_officer_1_name":"","company_officer_1_title":"","company_officer_2_name":"","company_officer_2_title":"","company_officer_3_name":"","company_officer_3_title":"","company_officer_4_name":"","company_officer_4_title":"","company_officer_5_name":"","company_officer_5_title":"","company_officers_update_time":"","get_dividend_history_year1":0,"get_dividend_history_year2":0,"get_dividend_history_year3":0,"get_dividend_history_year4":0,"get_dividend_history_year5":0,"get_dividend_history_year6":0,"get_dividend_history_year7":0,"get_dividend_history_year8":0,"get_dividend_history_year9":0,"get_dividend_history_year10":0,"site-sidebar-layout":"default","site-content-layout":"","ast-site-content-layout":"","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"","footer-sml-layout":"","theme-transparent-header-meta":"","adv-header-id-meta":"","stick-header-meta":"","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"default","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"jir_stock_code":"4565","jir_company_name":"NexThera Pharma Inc.","jir_importance":"\u2605\u2605\u2605\u2606\u2606","jir_publication_date":"2026-03-25","jir_source_link":"https:\/\/japanir.jp\/wp-content\/uploads\/2026\/03\/4565-20260325-01.pdf","jir_short_summary":"Resolved a new management structure effective March 25, 2026. Mr. Takeo Morooka was appointed as a new director, and Mr. Christopher Cargill was reappointed as Representative Executive Officer, President & CEO.","jir_summary":"### Overview of the New Management Structure\nAt the 36th Annual General Meeting of Shareholders and Board of Directors meeting held on March 25, 2026, the new management structure was resolved. Mr. Christopher Cargill was reappointed as Representative Executive Officer, President & CEO, and Mr. Takeo Morooka was newly appointed as a director. Mr. Morooka has extensive experience in corporate management, technology and R&D, business strategy, and marketing, and is expected to contribute to accelerating growth strategies and strengthening corporate governance.\n\n### Impact on Executive Structure and Corporate Strategy\nThere were some changes to the directors and executive officers, with outside directors primarily reappointed, maintaining a stable governance framework. The executive structure clearly defines key positions such as Chief Financial Officer and Chief Operating Officer, establishing a system to continue accelerating global expansion and pipeline development. This is expected to support the company\u2019s growth strategy and strengthen corporate governance.","jir_financial_highlights":"New Director: Takeo Morooka (New Appointment)\nRepresentative Executive Officer, President & CEO: Christopher Cargill (Reappointed) (Reappointment)\nOutside Directors: David Roblin, Rolf Sodastrom, Eiko Tomita, Naoko Shimura, Nicola Lawson (All Reappointed) (Reappointment)","jir_category":"","jir_hashtags":"#NexTheraPharmaInc, #executive_change, #JapaneseStocks","jir_key_figures":"New Director: Takeo Morooka (effective March 25, 2026)\nRepresentative Executive Officer, President & CEO: Christopher Cargill (Reappointed)\nNumber of Reappointed Outside Directors: 6","jir_meta_title":"NexThera Pharma Inc. Resolves New Management Structure, Appoints Takeo Morooka as New Director","jir_meta_description":"NexThera Pharma Inc. resolved a new management structure on March 25, 2026. Christopher Cargill was reappointed as Representative Executive Officer, President & CEO, and Takeo Morooka assumed office as a new director.","jir_og_title":"NexThera Pharma Announces New Management Structure and Appointment of New Director","jir_og_description":"Resolved a new management structure effective March 25, 2026. Takeo Morooka was appointed as new director, and Christopher Cargill was reappointed as Representative Executive Officer, President & CEO.","jir_og_image_url":"\/assets\/og\/company-general_ir.jpg","jir_chart_data_collection":"[]","ir_related_company":16880,"ir_release_date":"","ir_type":"","ir_is_new":false,"ir_document_url":"","jir_ir_type":"executive_change","footnotes":""},"sector":[],"importance":[],"class_list":["post-36608","ir_release","type-ir_release","status-publish","hentry"],"yoast_head":"\n